Naltrexone May Mitigate Stimulant-Induced Euphoria Associated With ADHD Treatment
Euphoria associated with the stimulant methylphenidate may be mitigated by co-administration of naltrexone in patients with attention-deficit/hyperactivity disorder.
Euphoria associated with the stimulant methylphenidate may be mitigated by co-administration of naltrexone in patients with attention-deficit/hyperactivity disorder.
Adult attention deficit hyperactivity disorder frequently co-occurs with fibromyalgia syndrome and may negatively affect FMS-related morbidity.
Children exposed to acetaminophen prenatally are at increased risk of multiple behavioral difficulties.